An audience of CLL patients and their caregivers joined us at a recent town meeting at The University of Texas MD Anderson Cancer Center to hear about emerging therapies in CLL, current treatment options and support resources.
We are also planning events in other cities. If you haven’t already, please sign up for email updates, so we can alert you when important and inspiring videos become available and when upcoming town meetings are scheduled.
What are monoclonal antibodies and why are they important for CLL patients? Drs. Zeev Estrov and Michael Keating explain.
Giving a thorough description of FISH and CLL profiling, Drs. Michael Keating and Nicole Lamanna emphasize the need to get the right test done at the right time to obtain the best targeted therapy.
Dr. Nicole Lamanna, PA Jamie Lynn Gibbons and Andrew discuss the importance of open dialogue with your healthcare team regarding treatment side effects.
Watch the afternoon session replay of the town meeting, “Living Well with Chronic Lymphocytic Leukemia: Education, Empowerment and Learning from Others.”
Watch the morning session replay of the town meeting, “Living Well with Chronic Lymphocytic Leukemia: Education, Empowerment and Learning from Others.”
Associate Clinical Professor of Medicine
Columbia University Medical Center
Host, Patient Power Co-Founder, CLL Patient and Advocate
Online Host, Patient Power Co-Founder, Caregiver and Patient Advocate
This town meeting was provided by CLL Global Research Foundation, which received support from AbbVie Inc., Genentech Inc., Gilead Sciences, Janssen Pharmaceuticals, Inc., Pharmacyclics, Inc. and Teva Pharmaceuticals. It was produced by Patient Power in partnership with The University of Texas MD Anderson Cancer Center.